Western blot analysis revealed that knockdown of AGAP2‐AS1 resulted in a significant decrease in nuclear factor‐kappaB (NF‐κB) and extracellular signal‐regulated kinase (ERK) 1/2 protein levels in glioma cells (Figure 10C). Here, AGAP2 is linked to central nervous system cancer.